Huntington Bancshares Incorporated (HBAN)

NASDAQ: HBAN · USD

$15.7

+0.00 (0.0%)· Recorded snapshot

İngilizce yedekTR

Çeviri yapılırken İngilizce kaynak gösteriliyor

Bu rapor henüz çevrilmedi. Çeviri kuyruğu yetiştiğinde birkaç dakika sonra sayfayı yenileyin.

StockMarketAgent Research · Analyzed 2026-10-05

Our latest published analysis: HBAN rated Strong Buy

Huntington Bancshares Incorporated's published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$20.8 / share

Potential value

$30.1 / share

Upside to FV

+35.8%

from $15.7

Moat

6.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$31.0B
Revenue (ttm)	9.8B
Net income (ttm)	2.3B
EPS (ttm)	$1.22
Shares out	2B
P/E (trailing)	12.8x
P/E (forward)	8.6x
Dividend	$0.62 (3.96%)
Volume	17,461,153
Beta	0.97

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9.8B
Net income (ttm): 2.3B
EPS (ttm): $1.22
P/E (trailing): 12.8x
P/E (forward): 8.6x
Market cap: $31.0B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$1.11B	$1.32B	$1.40B	$1.47B	$1.56B	+8.8%
Gross profit	$5.97B	$6.97B	$6.90B	$6.97B	$7.70B	+6.6%
Operating income	$1.59B	$2.76B	$2.38B	$2.40B	$2.69B	+14.0%
Net income	$1.30B	$2.24B	$1.95B	$1.94B	$2.21B	+14.3%
EPS (diluted)	$0.90	$1.45	$1.24	$1.22	$1.39	+11.5%
EBITDA	$1.98B	$3.25B	$3.18B	$3.03B	$3.45B	+14.9%
R&D	—	—	—	—	—	—
SG&A	$2.39B	$2.47B	$2.83B	$2.82B	$3.50B	+10.0%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	Sat
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	Azalt
ACN	Accenture plc	144.3B	18.0x	2.0x	27.9%	+8.0%	+0.4%	Tut
ACGL	Arch Capital Group Ltd.	34.8B	8.3x	1.8x	15.9%	+15.1%	+18.7%	Güçlü Al
AIG	American International Group Inc.	41.7B	14.7x	1.6x	7.7%	-9.6%	+2.8%	Güçlü Al
AIZ	Assurant, Inc.	14.1B	13.6x	1.0x	14.4%	+6.6%	+36.2%	Tut

Base and Bull scenarios

Base60%

Price target

$20.81

+35.7% from spot

The base case reflects orderly post-merger integration of Cadence and Veritex following the completion of the core systems conversion in mid-June 2026. Earning asset scale drives net interest income expansion, while fee platforms in payments, wealth management, and capital markets deliver steady growth. Synergies reduce operating expense intensity, allowing operating margins to normalize from 36.5% toward 40.5% by FY2029. Credit losses remain contained near historical norms with net charge-offs averaging 0.25%-0.30%, supporting disciplined capital distribution via dividends and opportunistic share buybacks.

House forecast EPS expands from $1.69 in FY2026 to $1.77 in FY2027 and $2.08 by FY2030
Operating margin expands from 36.5% in FY2026 to 40.5% in FY2029-FY2030 as integration synergies materialize
Cost of equity remains moderate at 8.468% with a 10.0x terminal P/E multiple
Reinvestment rate maintained at 8.0% of NOPAT with an effective tax rate of 18.1%

Bull20%

Price target

$30.13

+96.5% from spot

In the bull scenario, Huntington capitalizes aggressively on market share opportunities across high-growth Southeast markets acquired through Cadence and Texas operations from Veritex. Rapid cross-selling of capital markets, payments, and wealth products drives superior noninterest revenue expansion. Synergy realization exceeds management targets, driving the efficiency ratio below 55% and expanding ROTCE above 18%. Benign credit trends and expanding pre-provision net revenue enable accelerated share repurchases while sustaining healthy dividend growth.

EPS growth accelerates to 10% in Year 1, 7% in Year 2, and 5% in Year 3
Net interest margin expands above 3.35% driven by rapid deposit growth in Southeast expansion markets and lower funding costs
Fee income from advisory, payments, and wealth accelerates beyond double-digit growth rates
Annualized net charge-offs remain benign below 0.20% with CET1 ratio rising above 10.5%

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($20.81). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.0%	2.3%	2.5%	2.8%	3.0%
7.5%	$23.0	$23.9	$24.9	$26.0	$27.2
8.0%	$21.1	$21.9	$22.7	$23.6	$24.5
8.5%	$19.5	$20.1	$20.8	$21.5	$22.3
9.0%	$18.1	$18.7	$19.2	$19.8	$20.5
9.5%	$16.9	$17.4	$17.9	$18.4	$18.9

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E8.6

P25 n/aP50 n/aP75 n/a

Trailing P/E11.8

P25 n/aP50 n/aP75 n/a

ROE9.2

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All HBAN indicators

Market & fundamental data

Available fields

246

Groups with data

Currency

USD

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000049196
Company name	Huntington Bancshares Incorporated
Country	United States
Country code	US
CUSIP number	446150104
Earnings date	2026-10-22
Earnings time	bmo
Employees	25,527
Employees change	5,361
Employees growth	26.58%
Enterprise value	$37.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-09
Fiscal year end	December
Founded	1866
In index	SP500
Industry	Banks - Regional
Is primary listing	Yes
Is SPAC	No
ISIN number	US4461501045
Last 10-K release date	2026-02-13
Last earnings date	2026-10-22
Last refreshed	2026-10-28
Last stock split date	2000-07-12
Last stock split type	Forward
Market cap	$31.7B
Market cap category	Large-Cap
Next earnings date	2027-01-21
Options	Yes
Price	$15.71
Price currency	USD
Sector	Financials
SIC code	6021
Stock price date	2026-10-28
Symbol	HBAN
U.S. state	Ohio
Website	https://www.huntington.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	10.4x
Average P/E ratio (10Y)	13.37x
Average P/E ratio (3Y)	12.96x
Average P/E ratio (5Y)	12.26x
Earnings yield	7.79%
EV/Earnings	16.04x
EV/FCF	13.9x
EV/Sales	3.79x
FCF / EV yield	7.2%
FCF yield	8.48%
Forward EV/Sales	3.19x
Forward P/E	9.39x
Forward P/S	2.71x
Graham number	20.00331
Graham upside	27.49%
Industry forward P/E	9.97x
Industry P/E	11.81x
Lynch fair value	$20.88
Lynch upside	33.06%
P/B ratio	1.08x
P/E ratio	12.84x
P/FCF ratio	11.79x
P/OCF ratio	10.33x
P/S ratio	3.22x
PEG ratio	0.85x
Price / tangible book value	1.67x
Sector forward P/E	13.61x
Sector P/E	15.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Effective tax rate	18.24%
FCF margin	29.24%
Operating margin	35.13%
Pretax margin	31.18%
Profit margin	25.34%
Profit per employee	$91,041
Profitable quarters	21
Profitable years	16
Revenue per employee	$385,004
ROA	1.01%
ROA (5Y)	1.05%
ROE	9.19%
ROE (5Y)	10.17%
Tax / revenue	5.69%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-14.45%
EPS growth (Q)	-19.51%
EPS growth (QoQ)	0%
EPS growth 10Y	5.62%
EPS growth 3Y	-6.77%
EPS growth 5Y	6.51%
EPS growth years	1
FCF growth	37.8%
FCF growth 3Y	-1.59%
FCF growth 5Y	13.38%
Net income growth	12.06%
Net income growth (Q)	14.63%
Net income growth (QoQ)	-0.87%
Net income growth 3Y	1.55%
Net income growth 5Y	17.07%
Net income growth quarters	2
Net income growth years	1
OCF growth	44.16%
OCF growth 10Y	9.51%
OCF growth 3Y	1.1%
OCF growth 5Y	13.85%
Revenue growth	31.04%
Revenue growth (Q)	32.41%
Revenue growth (QoQ)	-1.26%
Revenue growth 10Y	12.29%
Revenue growth 3Y	10.82%
Revenue growth 5Y	12.81%
Revenue growth quarters	8
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-379M
EPS	$1.22
FCF per share	$1.33
Financing cash flow	$5.7B
Free cash flow	$2.7B
Gross profit	$9.8B
Income taxes	$559M
Investing cash flow	$-3.5B
Net borrowing	$1.5B
Net cash flow	$5.2B
Net income	$2.3B
Operating income	$3.5B
Revenue	$9.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$14.54
Debt / equity	0.73
Debt / FCF	8.72
Goodwill	$9.5B
Net cash (debt)	$-5.7B
Net cash / market cap	-17.92%
Net debt / equity	0.18
Net debt / FCF	2.11
Piotroski F-Score	4
Property, plant and equipment	$2.2B
Shareholders' equity	$32.2B
Tangible book value	$18.9B
Tangible book value per share	$9.38
Total assets	$287.8B
Total cash	$17.7B
Total debt	$23.4B
Total liabilities	$255.6B
WACC	5.52%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Working capital	$-208.2B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-27.64%
Dividend growth	0%
Dividend growth (10Y)	7.89%
Dividend growth (3Y)	0%
Dividend growth (5Y)	0.49%
Dividend growth years	0
Dividend payment date	2027-01-04
Dividend payment years	56
Dividend payout frequency	Quarterly
Dividend per share	$0.62
Dividend yield	3.96%
Ex-dividend date	2026-12-18
FCF payout ratio	46.57%
Last dividend	$0.16
Payout ratio	50.68%
Shareholder yield	-23.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	46.23%
10Y return CAGR	8.3%
10Y total return	122.01%
150-day SMA	$16.58
15Y price change	191.11%
15Y return CAGR	11.32%
15Y total return	399.26%
1D price change	0%
1M price change	0.51%
1M total return	0.51%
1W price change	1.16%
1W total return	1.16%
1Y price change	0.51%
1Y return CAGR	4.38%
1Y total return	4.38%
20-day SMA	$15.42
200-day SMA	$16.71
20Y price change	-35.12%
20Y return CAGR	1.4%
20Y total return	32.14%
3M price change	-8.39%
3M total return	-7.49%
3Y price change	66.53%
3Y return CAGR	23.5%
3Y total return	88.37%
50-day SMA	$16.01
50-day SMA vs 200-day SMA	50under200
52-week high	$19.46
52-week high date	2026-02-06
52-week low	$14.82
52-week low date	2026-10-01
5Y price change	-1.57%
5Y return CAGR	4.19%
5Y total return	22.78%
6M price change	-4.9%
6M total return	-3.09%
All-time high	$30.89
All-time high date	1999-06-04
All-time low	$1.00
All-time low date	2009-02-20
Average true range (ATR)	$0.31
Average volume	24.4M
Beta (1Y)	0.68
Beta (2Y)	1.16
Beta (5Y)	0.97
Change from 52-week high	-19.25%
Change from 52-week low	6.01%
Change from all-time high	-49.11%
Change from all-time low	1,472%
Change from open	-0.13%
Day's gap	0.13%
Dollar volume	$274.3M
High price	$15.77
Low price	$15.59
Monthly RSI	48.91
Open price	$15.73
Position in 52-week range	66.67%
Premarket change	0.25%
Premarket close	$15.71
Premarket price	$15.75
Previous close	$15.71
Price vs 150-day SMA	-5.25%
Price vs 20-day SMA	1.88%
Price vs 200-day SMA	-5.97%
Price vs 50-day SMA	-1.87%
Relative volume	0.72
RSI	51.93
Sharpe ratio	0.14
Sharpe ratio (3Y)	0.73
Sharpe ratio (5Y)	0.13
Sortino ratio	0.4
Sortino ratio (3Y)	1.28
Sortino ratio (5Y)	0.36
Volume	17.5M
Weekly RSI	42.96
YTD price change	-9.39%
YTD total return	-6.73%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2B
Float percentage	99.34%
Shares change (QoQ)	-0.06%
Shares change (YoY)	27.64%
Shares held by insiders	0.55%
Shares held by institutions	89.14%
Shares outstanding	2B
Short % of float	3.37%
Short % of shares	3.35%
Short ratio	1.8 days

Deeper analysis on HBAN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this HBAN report

What is the latest published HBAN stock rating?

Huntington Bancshares Incorporated is shown with Strong Buy in the latest published report, analyzed 2026-10-05. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HBAN analysis?

The full latest published report, analyzed 2026-10-05, lives at /stocks/HBAN/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for HBAN?

The latest published report analyzed 2026-10-05 gives HBAN a fair value of USD 21 and a potential value of USD 30. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the HBAN page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-05). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Strong BuyHBAN · Fair value $20.8+35.8%

Read full analysis →

Huntington Bancshares Incorporated (HBAN)

Our latest published analysis: HBAN rated Strong Buy

Price

Financial snapshot

Fair-value bridge

Latest news · HBAN

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All HBAN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HBAN

Frequently asked questions

Derecelendirme geçmişi

Category	Score	Reading
Valuation	8.5
Management	7.5
Balance Sheet	5.0
Profitability	6.5
Revenue Growth	9.0
Risk Assessment	6.0
Competitive Moat	6.5
Earnings Quality	6.0
Capital Efficiency	4.0